Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a patch boost arousal? new study tests At-Home nerve zapping for women

NCT ID NCT06932302

Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study from the University of Michigan is testing whether a non-invasive nerve stimulation device, used at home, can improve sexual arousal in women with female sexual dysfunction. Twenty-four participants will use the UCon patch system to stimulate the dorsal genital nerve, while some will also use a smart vibrator for comparison. The main goal is to see if women can follow the treatment schedule and if it helps with arousal symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electrical stimulation device (UCon patch system) and smart vibrator
What this could lead to
If successful, this could offer a non-invasive, at-home treatment option to improve sexual arousal symptoms in women.
What could go wrong
This is a very small pilot study (24 participants) focused on feasibility, not proof of effectiveness. The device may cause minor side effects like skin irritation or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Capable of speaking and understanding English. * Able to comprehend the clinical study procedures and provide informed consent. * Identified as having female sexual dysfunction with a Female Sexual Function Index (FSFI) score of 26.55 or less and a score of 3 or less on one or more of the FSFI subdomains of lubrication, arousal, and orgasm. * Willing and able to adhere to the study protocol * Able to attend experimental sessions at Michigan Medicine at both the start and conclusion of the study. Exclusion Criteria: * Not currently sexually active. * Pregnant or planning to get pregnant during the study period. * History of a neurological disorder or impairments affecting pelvic organ function, including diagnosed with dorsal genital nerve damage, lower motor dysfunction, or other related conditions. * Implanted with a neurostimulator for bladder or bowel function. * Have a skin condition that would predispose them to sensitivity to the stimulation electrodes. * Female sexual dysfunction limited solely to low desire, without issues in lubrication, arousal, or orgasm. * Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic organ symptoms; or a score of 8 or higher on the American Urological Association Symptom Index (AUASI). * Unable or unwilling to adhere to the study protocol * Simultaneously participating in another research study that may affect the results of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female sexual dysfunction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female sexual dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.